Medicofarma Biotech

Medicofarma Biotech Tangible Book Value per Share

The Tangible Book Value per Share of Medicofarma Biotech (MDB.WA) as of Oct 17, 2026 is 0.08 PLN. In the previous year, Tangible Book Value per Share was 0.10 PLN — a change of -16.13% (lower).

Tangible Book Value per Share

0.08PLN

YoY

-16.13%

Last updated:

Tangible Book Value per Share of Medicofarma Biotech is 2025 0.08 PLN. Tangible Book Value per Share of Medicofarma Biotech was 2024 0.10 PLN. It decreases by -16.13% lower compared to the previous year.

The Medicofarma Biotech Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
0.01 PLN
Jan 1, 2019
0.01 PLN
Jan 1, 2020
-0.00 PLN
Jan 1, 2021
0.18 PLN
Jan 1, 2022
0.16 PLN
Jan 1, 2023
0.13 PLN
Jan 1, 2024
0.10 PLN
Jan 1, 2025
0.08 PLN
The Medicofarma Biotech Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
0.08PLN-16.13%
0.10PLN-24.91%
0.13PLN-18.54%
0.16PLN-9.35%
0.18PLN-5,413.04%
-0.00PLN-138.33%
0.01PLN-31.82%
0.01PLN+11.39%
0.01PLN+12.86%
0.01PLN+9.38%
0.01PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medicofarma Biotech Stock analysis

What does Medicofarma Biotech do? Medicofarma Biotech SA is a biotechnology company based in Warsaw, Poland. The company is listed on the Warsaw Stock Exchange under the ticker MDB.WA and has an ISIN code of PLINBOK00010. It operates within the Health Care sector, specifically in the Life Sciences Tools & Services industry. Medicofarma Biotech SA completed its initial public offering (IPO) on November 27, 2008. The company focuses on the development and production of innovative medicines, medicinal products, and biotechnology products. Its research and development activities are conducted in laboratories located in Lublin and Poznan, Poland. The company's headquarters are situated in Warsaw, within the Mazowieckie region. Medicofarma Biotech SA's website is https://medicofarmabiotech.pl/. The company is engaged in the development of drugs, medical devices, and biotechnological products. It operates as a public company with a presence in multiple cities across Poland, including Warsaw, Lublin, and Poznan. The company's primary activities involve the research, development, and commercialization of biotechnology-based solutions for the healthcare sector. Medicofarma Biotech SA is registered in Poland and serves the broader European market with its products and services. Medicofarma Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicofarma Biotech stock

Tangible Book Value per Share of Medicofarma Biotech is 0.08 PLN in 2025.

Tangible Book Value per Share of Medicofarma Biotech changed from 0.10 PLN to 0.08 PLN, representing a -16.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Medicofarma Biotech since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Medicofarma Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Medicofarma Biotech